Pooled genome wide association detects association upstream of FCRL3 with Graves' disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27863461)

Published in BMC Genomics on November 18, 2016

Authors

Jwu Jin Khong1,2,3, Kathryn P Burdon4, Yi Lu5, Kate Laurie6, Lefta Leonardos6, Paul N Baird7, Srujana Sahebjada7, John P Walsh8,9, Adam Gajdatsy10, Peter R Ebeling11, Peter Shane Hamblin12,13, Rosemary Wong13, Simon P Forehan14, Spiros Fourlanos14, Anthony P Roberts15, Matthew Doogue16, Dinesh Selva17, Grant W Montgomery18, Stuart Macgregor5, Jamie E Craig6

Author Affiliations

1: Melbourne Medical School Western Campus, Department of Medicine, University of Melbourne, Sunshine Hospital, 176 Furlong Road, St Albans, VIC, 3021, Australia. jwujinkhong@gmail.com.
2: Orbital, Plastics and Lacrimal Unit, The Royal Victorian Eye and Ear Hospital, Heidelberg, VIC, Australia. jwujinkhong@gmail.com.
3: Department of Ophthalmology and Department of Surgery, University of Melbourne, Austin Health, Heidelberg, VIC, Australia. jwujinkhong@gmail.com.
4: Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
5: Statistical Genetics, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Herston, QLD, Australia.
6: Department of Ophthalmology, Flinders University of South Australia, Bedford Park, South Australia, Australia.
7: Department of Surgery, Centre for Eye Research Australia and Ophthalmology, University of Melbourne, East Melbourne, VIC, Australia.
8: Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.
9: School of Medicine and Pharmacology, The University of Western Australia, Crawley, WA, Australia.
10: Centre for Ophthalmology and Visual Sciences, University of Western Australia, Western Australia, Australia.
11: Department of Medicine, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.
12: Melbourne Medical School Western Campus, Department of Medicine, University of Melbourne, Sunshine Hospital, 176 Furlong Road, St Albans, VIC, 3021, Australia.
13: Department of Endocrinology and Diabetes, Western Health, St Albans, VIC, Australia.
14: Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Parkville, VIC, Australia.
15: Department of Endocrinology, The Royal Adelaide Hospital, Adelaide, South Australia, Australia.
16: Department of Medicine, University of Otago, Christchurch, New Zealand.
17: South Australian Institute of Ophthalmology, University of Adelaide, South Australia, Australia.
18: Molecular Epidemiology, Queensland Institute of Medical Research (QIMR) Berghofer Medical Research Institute, Herston, QLD, Australia.

Articles cited by this

PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet (2007) 12.62

Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol (1997) 5.94

Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet (2008) 3.79

Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol (Oxf) (2007) 3.17

A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet (2005) 3.15

Highly cost-efficient genome-wide association studies using DNA pools and dense SNP arrays. Nucleic Acids Res (2008) 3.08

The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab (2004) 2.44

Smoking and risk of Graves' disease. JAMA (1993) 2.35

The epidemiology of autoimmune diseases. Autoimmun Rev (2003) 2.31

Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab (2001) 2.10

A genome-wide association study identifies two new risk loci for Graves' disease. Nat Genet (2011) 1.92

Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev (2003) 1.85

Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci U S A (2001) 1.84

The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun (2009) 1.81

A population-based study of Graves' disease in Danish twins. Clin Endocrinol (Oxf) (1998) 1.67

The environment and autoimmune thyroid diseases. Eur J Endocrinol (2004) 1.66

Fc receptor-like molecules. Annu Rev Immunol (2007) 1.58

Seven newly identified loci for autoimmune thyroid disease. Hum Mol Genet (2012) 1.57

Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J Clin Endocrinol Metab (2007) 1.57

Common genetic variants near the Brittle Cornea Syndrome locus ZNF469 influence the blinding disease risk factor central corneal thickness. PLoS Genet (2010) 1.55

Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin Endocrinol (Oxf) (2003) 1.48

Most pooling variation in array-based DNA pooling is attributable to array error rather than pool construction error. Eur J Hum Genet (2007) 1.46

Rapid inexpensive genome-wide association using pooled whole blood. Genome Res (2009) 1.41

A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid (2002) 1.41

Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab (2006) 1.37

Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol Neurobiol (2011) 1.33

Association of polymorphisms in the hepatocyte growth factor gene promoter with keratoconus. Invest Ophthalmol Vis Sci (2011) 1.29

Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. J Clin Endocrinol Metab (2005) 1.27

Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease. Hum Mol Genet (2009) 1.26

IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells. Blood (2002) 1.22

Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset. Clin Endocrinol (Oxf) (2005) 1.11

The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun (2009) 1.07

Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) (2007) 1.06

Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis. Ann Rheum Dis (2006) 1.05

Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations. Eur J Endocrinol (2003) 1.03

Sibling recurrence risk in autoimmune thyroid disease. Thyroid (2003) 1.00

Association of the T-cell regulatory gene CTLA4 with Graves' disease and autoimmune thyroid disease in the Japanese. J Hum Genet (2004) 1.00

Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population. Arthritis Rheum (2006) 0.98

Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease. Thyroid (2005) 0.98

Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid (2001) 0.97

MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet (2001) 0.97

GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nat Rev Endocrinol (2013) 0.96

A role for the neuronal protein collapsin response mediator protein 2 in T lymphocyte polarization and migration. J Immunol (2005) 0.95

The functional -169T-->C single-nucleotide polymorphism in FCRL3 is not associated with rheumatoid arthritis in white North Americans. Arthritis Rheum (2006) 0.95

Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration. J Biol Chem (2009) 0.93

A refined study of FCRL genes from a genome-wide association study for Graves' disease. PLoS One (2013) 0.89

Human T lymphotropic virus type 1 increases T lymphocyte migration by recruiting the cytoskeleton organizer CRMP2. J Immunol (2012) 0.86

Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population. Thyroid (2008) 0.86

The FCRL3 -169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases. Ann Rheum Dis (2007) 0.85

The -169C/T polymorphism in FCRL3 is not associated with susceptibility to rheumatoid arthritis or systemic lupus erythematosus in a case-control study of Koreans. Arthritis Rheum (2006) 0.85

Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women. Clin Endocrinol (Oxf) (1996) 0.85

Identification of independent risk loci for Graves' disease within the MHC in the Japanese population. J Hum Genet (2011) 0.84

Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients. Eur J Intern Med (2009) 0.82

CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy. Lancet (1999) 0.81

Comparison of genotyping using pooled DNA samples (allelotyping) and individual genotyping using the affymetrix genome-wide human SNP array 6.0. BMC Genomics (2013) 0.78

New single nucleotide polymorphisms associated with differences in platelets reactivity in patients with type 2 diabetes treated with acetylsalicylic acid: genome-wide association approach and pooled DNA strategy. J Thromb Thrombolysis (2013) 0.78

HLA-DRB1*03 is a susceptibility gene in patients with Graves' disease with and without ophthalmopathy. Int J Immunogenet (2007) 0.76